Last reviewed · How we verify
NCT03541824
Reducing Suicide Risk Associated With Weight Loss
NA trial testing Body Acceptance Program in Eating Behavior in 59 participants. Completed in 20 March 2017.
20 March 2017
Quick facts
| Lead sponsor | Florida State University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 59 |
| Start date | 1 July 2016 |
| Primary completion | 20 March 2017 |
| Estimated completion | 20 March 2017 |
Drugs / interventions tested
- Body Acceptance Program
Conditions studied
- Eating Behavior — all drugs for Eating Behavior →
- Self Harm — all drugs for Self Harm →
- Weight Loss — all drugs for Weight Loss →
Sponsor
Florida State University
Who can join
Adults 18 to 65, any sex, with Eating Behavior or Self Harm. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to examine the efficacy of an intervention aimed at promoting a healthy lifestyle and reducing risk factors associated with eating pathology, nonsuicidal self-injury, and suicidal behavior. We are also interested in assessing whether this intervention has the potential to prevent future symptoms of eating problems and self-harm urges and behaviors. The broader goal of this research is to identify factors that may help us better understand the prevention of self-harm behaviors and develop more effective treatments for these problems.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Psychosocial interventions for self-harm in adults.
Witt KG, Hetrick SE, Rajaram G, Hazell P, et al · · 2021 · cited 79× · PMID 33884617 · DOI 10.1002/14651858.cd013668.pub2
Verify or expand the search:
- PubMed search for NCT03541824
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Eating Behavior
Currently open trials in the same condition.
- NCT06551974 — INTERconNEcT-Eds: a Guided Self-help Mobile App to Improve Outcome in Eating Disorders · NA · recruiting
- NCT07348432 — The diabEAT Study: Insulin dElivery Technologies And eaTing Behaviours in People With Type 1 Diabetes · recruiting
- NCT06175988 — Visceral Adiposity, Vagal Tone and Food Preferences: a Pilot Study · recruiting
- NCT06145009 — Time Restricted Eating, Eating Behaviors, and Cardiometabolic Risk in Emerging Adult Women · NA · recruiting
- NCT06108128 — Food for Thought: Executive Functioning Around Eating Among Children · NA · recruiting
Other Florida State University trials
Trials by the same sponsor.
- NCT06127914 — Learning Early Infant Feeding Cues · NA · not yet recruiting
- NCT06015581 — Scaling Up Implementation Strategies to Improve the DIAGNOSE and PREVENT Pillars for Young MSM in Florida · NA · not yet recruiting
- NCT07467473 — Causal Role of Rostromedial Prefrontal Cortex for Positive Savoring in Depression · NA · enrolling by invitation
- NCT07221448 — Sodium vs Potassium Education to Improve Vascular Health · NA · recruiting
- NCT07415941 — MBM and taVNS for Low Back Pain and Depressive Symptoms · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03541824 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Florida State University
- Last refreshed: 31 May 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03541824.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing